Ascelia Pharma (Sweden) Market Value
| ACE Stock | SEK 2.90 0.11 3.65% |
| Symbol | Ascelia |
Ascelia Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ascelia Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ascelia Pharma.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in Ascelia Pharma on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Ascelia Pharma AB or generate 0.0% return on investment in Ascelia Pharma over 720 days. Ascelia Pharma is related to or competes with Hansa Biopharma, Cantargia, Saniona AB, BioArctic, and Alligator Bioscience. Ascelia Pharma AB operates as an oncology focused specialty pharmaceutical company that develops medicines to enhance th... More
Ascelia Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ascelia Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ascelia Pharma AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.91 | |||
| Information Ratio | 0.0787 | |||
| Maximum Drawdown | 38.06 | |||
| Value At Risk | (3.98) | |||
| Potential Upside | 12.92 |
Ascelia Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ascelia Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ascelia Pharma's standard deviation. In reality, there are many statistical measures that can use Ascelia Pharma historical prices to predict the future Ascelia Pharma's volatility.| Risk Adjusted Performance | 0.0882 | |||
| Jensen Alpha | 0.211 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.109 | |||
| Treynor Ratio | 0.2061 |
Ascelia Pharma AB Backtested Returns
Ascelia Pharma appears to be very risky, given 3 months investment horizon. Ascelia Pharma AB secures Sharpe Ratio (or Efficiency) of 0.1, which signifies that the company had a 0.1% return per unit of standard deviation over the last 3 months. By analyzing Ascelia Pharma's technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please makes use of Ascelia Pharma's risk adjusted performance of 0.0882, and Mean Deviation of 3.47 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ascelia Pharma holds a performance score of 8. The firm shows a Beta (market volatility) of 2.69, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ascelia Pharma will likely underperform. Please check Ascelia Pharma's semi deviation, sortino ratio, semi variance, as well as the relationship between the standard deviation and value at risk , to make a quick decision on whether Ascelia Pharma's price patterns will revert.
Auto-correlation | 0.80 |
Very good predictability
Ascelia Pharma AB has very good predictability. Overlapping area represents the amount of predictability between Ascelia Pharma time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ascelia Pharma AB price movement. The serial correlation of 0.8 indicates that around 80.0% of current Ascelia Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.8 | |
| Spearman Rank Test | 0.71 | |
| Residual Average | 0.0 | |
| Price Variance | 11.55 |
Ascelia Pharma AB lagged returns against current returns
Autocorrelation, which is Ascelia Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ascelia Pharma's stock expected returns. We can calculate the autocorrelation of Ascelia Pharma returns to help us make a trade decision. For example, suppose you find that Ascelia Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ascelia Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ascelia Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ascelia Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ascelia Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Ascelia Pharma Lagged Returns
When evaluating Ascelia Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ascelia Pharma stock have on its future price. Ascelia Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ascelia Pharma autocorrelation shows the relationship between Ascelia Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Ascelia Pharma AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ascelia Stock Analysis
When running Ascelia Pharma's price analysis, check to measure Ascelia Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascelia Pharma is operating at the current time. Most of Ascelia Pharma's value examination focuses on studying past and present price action to predict the probability of Ascelia Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascelia Pharma's price. Additionally, you may evaluate how the addition of Ascelia Pharma to your portfolios can decrease your overall portfolio volatility.